Comments
Cadila Healthcare Ltd on Wednesday said it has received the final approval from the US heath regulator (USFDA) to market generic cholesterol-lowering Colesevelam Hydrochloride tablets with strength of 625 mg. The product will be manufactured at the group’s formulations facility at SEZ, Ahmedabad. The medication is be given along with proper diet and exercise to lower cholesterol levels. The group has 273 approvals and has so far filed over 360 ANDAs.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.